PPT-THE FDA WEBSITE

Author : min-jolicoeur | Published Date : 2017-11-04

IMPROVING TRANSPARENCY AND EFFECTIVENESS Stephen A Weitzman JD LLM GOAL My goal today is to recruit you in an effort to get FDA to devote more resources to meet

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "THE FDA WEBSITE" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

THE FDA WEBSITE: Transcript

IMPROVING TRANSPARENCY AND EFFECTIVENESS Stephen A Weitzman JD LLM GOAL My goal today is to recruit you in an effort to get FDA to devote more resources to meet your information needs FOIA . 1061 Rockville MD 20852 All comments should be identified with the docket number listed in the notice of availability that is published in the Federal Register For questions rega rding this document contact Michael Ortwerth at 301 796 8220 US Depart MARCH 2011 Consumer Health Information www.fda.gov/consumer FDA Intends to Remove Unapproved Drugs from Market F DA announced Wednesday remove certain unapproved prescription medicines intended Patricia Kovacevic. Director, Regulatory . Affairs & Associate . General Counsel. Lorillard Tobacco Company. Presentation before FDLI September 11, 2013 webinar audience. Nothing in this presentation should be construed as forward-looking statements for investment purposes. James C. Shehan. Hyman, Phelps & McNamara, P.C.. 700 Thirteenth Street, N.W., Suite 1200. Washington, D.C. 20005, U.S.A.. 202-737-9634 .  . jshehan@hpm.com. October 29, 2014. Agenda. BPCIA Overview. At . the end of this module, you will be . able to recall . FDA regulations . related to pharmaceutical . advertising . with 100% . accuracy. MODULE OBJECTIVE. Pharmaceutical companies spend millions of dollars on drug advertising . SUPPLEMENTAL MATERIAL. Version: 12-7-17. Business Size. Compliance Dates. For Most Produce. Proposed . Water Related Compliance. Dates. All. other. businesses (>$500K). 1/26/18. 1/26/22. Small businesses . For innovation to be successful, it needs to be more than just a buzz word.. www.fda.gov. Why Innovation?. WHY innovation?. Why Innovation?. 42% of millennials are . leaving . jobs because of substandard . Division of Human Food Safety. Office of New Animal Drug Evaluation. Center for Veterinary Medicine. US Food and Drug Administration. Human Food Safety of New Animal Drugs: . Toxicology Assessment. 6/14/2012. SUPPLEMENTAL MATERIAL. Version: . 07-31-18. Business Size. Compliance Dates. For Most Produce. Proposed . Water Related Compliance. Dates. All. other. businesses (>$500K). 1/26/18. 1/26/22. Small businesses . Tina Morrison, Ph.D.. Chair, Modeling and Simulation Working Group. Office of the Chief Scientist. Deputy Director, Division of Applied Mechanics. Office of Science and Engineering Laboratories. U.S. Food and Drug Administration. La gamme de thé MORPHEE vise toute générations recherchant le sommeil paisible tant désiré et non procuré par tout types de médicaments. Essentiellement composé de feuille de morphine, ce thé vous assurera d’un rétablissement digne d’un voyage sur . James D. McKean, DVM, JD. Associate Director, Iowa Pork Industry Center, . Iowa State University. x2mckean@iastate.edu. Future of . Antimicrobials. Disclaimer. - My “CRYSTAL BALL” . may be . cracked !!!. MSACL. April 4, 2019. Majda Haznadar, Kris Roth, Doug Jeffery. majda.haznadar@fda.hhs.gov. kristian.roth@fda.hhs.gov. doug.jeffery@fda.hhs.gov. www.fda.gov. www.fda.gov. DISCLAIMER. This presentation is intended for informational purposes only and does not constitute legal or regulatory advice. Please see the Federal Food, Drug, and Cosmetic Act and 21 CFR Subchapter H for a full list of requirements by FDA. precision.fda.gov | precisionFDA@fda.hhs.gov | @precisionFDA. Taha A. Kass-Hout, MD, MS. FDA Chief Health Informatics . Officer. Director, FDA’s Office of Health . Informatics. David . Litwack. , PhD.

Download Document

Here is the link to download the presentation.
"THE FDA WEBSITE"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.